Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Central nervous system (CNS) receptors are a broad and heterogeneous class of proteins located within the brain and spinal cord that mediate the effects of neurotransmitters, hormones, and drugs [1]. This term does not refer to a single molecular entity but serves as a collective designation for various receptor families, including G protein-coupled receptors (GPCRs), ligand-gated ion channels (ionotropic receptors), and nuclear receptors [2]. These receptors are fundamental to the regulation of all neurological processes, such as synaptic transmission, neuronal excitability, and signal transduction pathways that govern behavior, cognition, and motor control [3]. Dysregulation or genetic mutations in specific CNS receptors are implicated in a wide array of pathologies, including Alzheimer's disease, schizophrenia, epilepsy, and major depressive disorder [4]. Because of their central role in physiology, they are the primary targets for a vast number of pharmacological interventions, including analgesics, antipsychotics, and antidepressants [5]. However, the development of drugs targeting CNS receptors is uniquely challenging due to the requirement for blood-brain barrier penetration and the need for high subtype selectivity to avoid significant side effects [6].
Varies by specific receptor subtype; includes agonism, antagonism, and allosteric modulation of signal transduction or ion flux.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Central nervous system receptor.